Expansion Therapeutics hauls in $55.3 mln Series A

San Diego and Jupiter, Florida-based Expansion Therapeutics, a developer of ribonucleic acid targeted small molecule medicines, has secured $55.3 million in Series A financing. The lead investors were 5AM Ventures, Kleiner Perkins, Novartis Venture Fund and Sanofi Ventures. Also, RA Capital Management and Alexandria Venture Investments participated in the round.

Source: Press Release